Chapter 2 (The political economy of the right to health: a terrain for contestation) introduces the concept of political economy as a "terrain for contestation" where global markets and local governments collide, and where inequalities between developed and developing countries are deepened or, in some cases, challenged. Building from the notion of political economy as a field of contention, I discuss some of the coalitions formed by Big Pharma and a diverse array of stakeholders - doctors, patients' organizations, scientists - to resist the regulatory agendas of governments aimed at making drugs more affordable and to reject the challenges of competitors such as generic and biosimilar drugs producers.
Institutional Login
Log in with Open Athens, Shibboleth, or your institutional credentials
Personal login
Log in with your Elgar Online account